Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma
| Image |  |
|---|---|
| Description | scientific article published on 14 May 2020 |
| Author/s |
author: Martina Manni Carlo Visco Stefano Luminari |
| Publication date | May 14, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |